These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 38398130)

  • 21. Management of locally advanced intrahepatic cholangiocarcinoma: a narrative review.
    Bressler L; Bath N; Manne A; Miller E; Cloyd JM
    Chin Clin Oncol; 2023 Apr; 12(2):15. PubMed ID: 37038054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical Therapy of Cholangiocarcinoma.
    Radtke A; Königsrainer A
    Visc Med; 2016 Dec; 32(6):422-426. PubMed ID: 28229077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical management, including the role of transplantation, for intrahepatic and peri-hilar cholangiocarcinoma.
    Malik AK; Davidson BR; Manas DM
    Eur J Surg Oncol; 2024 Mar; ():108248. PubMed ID: 38467524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The state of therapy modalities in clinic for biliary tract cancer.
    Chen W; Hu Z; Song J; Wu Y; Zhang B; Zhang L
    Front Biosci (Landmark Ed); 2022 Jun; 27(6):185. PubMed ID: 35748261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma.
    Akateh C; Ejaz AM; Pawlik TM; Cloyd JM
    World J Hepatol; 2020 Oct; 12(10):693-708. PubMed ID: 33200010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted Therapies for Perihilar Cholangiocarcinoma.
    Gray S; Lamarca A; Edeline J; Klümpen HJ; Hubner RA; McNamara MG; Valle JW
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma.
    Serifis N; Tsilimigras DI; Cloonan DJ; Pawlik TM
    Hepat Med; 2021; 13():93-104. PubMed ID: 34754247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins.
    Glazer ES; Liu P; Abdalla EK; Vauthey JN; Curley SA
    J Gastrointest Surg; 2012 Sep; 16(9):1666-71. PubMed ID: 22777053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrating cytotoxic, targeted and immune therapies for cholangiocarcinoma.
    Merters J; Lamarca A
    J Hepatol; 2023 Mar; 78(3):652-657. PubMed ID: 36400328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant gemcitabine therapy improves survival in a locally induced, R0-resectable model of metastatic intrahepatic cholangiocarcinoma.
    Gürlevik E; Fleischmann-Mundt B; Armbrecht N; Longerich T; Woller N; Kloos A; Hoffmann D; Schambach A; Wirth TC; Manns MP; Zender L; Kubicka S; Kühnel F
    Hepatology; 2013 Sep; 58(3):1031-41. PubMed ID: 23686746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrahepatic cholangiocarcinoma: expert consensus statement.
    Weber SM; Ribero D; O'Reilly EM; Kokudo N; Miyazaki M; Pawlik TM
    HPB (Oxford); 2015 Aug; 17(8):669-80. PubMed ID: 26172134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy for cholangiocarcinoma: An update.
    Ramírez-Merino N; Aix SP; Cortés-Funes H
    World J Gastrointest Oncol; 2013 Jul; 5(7):171-6. PubMed ID: 23919111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging Therapies in Management of Cholangiocarcinoma.
    Speckart J; Rasmusen V; Talib Z; GnanaDev DA; Rahnemai-Azar AA
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical management of biliary tract cancers.
    Fairweather M; Balachandran VP; D'Angelica MI
    Chin Clin Oncol; 2016 Oct; 5(5):63. PubMed ID: 27829277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy.
    Mauro E; Ferrer-Fàbrega J; Sauri T; Soler A; Cobo A; Burrel M; Iserte G; Forner A
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: a systematic review.
    Grendar J; Grendarova P; Sinha R; Dixon E
    HPB (Oxford); 2014 Apr; 16(4):297-303. PubMed ID: 23981000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interventional Radiology Locoregional Therapies for Intrahepatic Cholangiocarcinoma.
    Woodhead G; Lee S; Struycken L; Goldberg D; Hannallah J; Young S
    Life (Basel); 2024 Feb; 14(2):. PubMed ID: 38398726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Era of Immune-Based Therapy in Intrahepatic Cholangiocarcinoma.
    Kawamura E; Matsubara T; Kawada N
    Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrahepatic cholangiocarcinoma: current management and emerging therapies.
    Rahnemai-Azar AA; Weisbrod AB; Dillhoff M; Schmidt C; Pawlik TM
    Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):439-449. PubMed ID: 28317403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of adjuvant and neoadjuvant therapy for resectable biliary tract cancer.
    Nara S; Esaki M; Ban D; Takamoto T; Mizui T; Shimada K
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):537-545. PubMed ID: 33793366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.